Evidence-Based Drug Policy Act of 2025
This bill repeals a specific provision (section 704(b)(12)) from the 1998 Office of National Drug Control Policy Reauthorization Act. The text provided does not explain what policy or requirement was contained in the repealed section, so the specific policy change or who it directly affected cannot be determined from the given context. Without details on the repealed provision's content, a summary of mechanisms, key provisions, or affected parties cannot be accurately provided. The bill appears to be a procedural repeal with no additional substantive provisions described in the excerpt.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
President
Introduced Apr 29, 2025
Last action Apr 29, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 29, 2025
Committee
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 29, 2025
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dina Titus
DDemocratic
Co
Eleanor Holmes Norton
DDemocratic
Co
Ilhan Omar
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3082
Scope: US
Hi! I can help you understand HR 3082. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline